Neuralink, Elon Musk's brain implant venture, is reaching out to major U.S. neurosurgery centers to potentially begin testing its devices on humans, according to a Reuters report. Before that can happen though, the U.S. government needs to grant the company approval, which is far from certain. In 2022, the U.S. Food and Drug Administration rejected its application to proceed with human trials due to safety concerns. Neuralink has been working to address those concerns ever since.
The Centers for Disease Control and Prevention recently recommended for the first time that pregnant people get the RSV vaccine to protect their babies from severe disease but a recent report found concerns about vaccinations during pregnancy.
And as the 2024 presidential election cycle heats up, a group known as Climate Power is set to air $80 million in ads to spotlight the work done by President Joe Biden on the environment and climate.
